Irving, Texas — According to state and local economic development sources Caris Life Sciences plans to invest $40,000,000.00 to build out 76,000 square feet of new space in Irving. The company plans to occupy the new space at 3600 W Royal Lane in Irving, on or about January 1, 2024. According to the company website Caris Life Sciences (Caris) is a molecular science company developing and delivering technologies to revolutionize healthcare. The Company’s suite of market-leading molecular profiling offerings assesses DNA, RNA and proteins to reveal a molecular blueprint that helps patients, physicians and researchers improve outcomes and save lives. Caris is also advancing precision medicine through advanced artificial intelligence (AI) and machine learning algorithms. Leveraging the Company’s proprietary AI analytics engine, DEAN, across its extensive catalog of molecular intelligence and clinical outcomes data, Caris is actively developing a better understanding of the molecular mechanisms of cancer in ways never before possible. This information provides an unmatched resource to help physicians better identify and predict patient response to therapy, as well as support researchers and biopharmaceutical companies derive unique insights for research development, clinical trials and target identification. Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Denver, Tokyo, Japan and Basel, Switzerland. Caris provides services throughout the U.S., Europe, Asia and other international markets.

To learn more about Caris Life Sciences, visit http://www.carislifesciences.com/

Company Contact:
David Halbert, Chief Executive Officer
866-771-8946

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved